Norwegian Cruise Line Holdings Ltd. locks in Italian shipyard capacity for next-generation fleet expansion (NYSE: NCLH)
Norwegian Cruise Line Holdings Ltd. locks in three new ships through 2037. Discover what this means for growth, leverage, and cruise industry competition.
Will this United Airlines engine deal cement GE Aerospace’s grip on long-haul aviation economics?
United Airlines orders 300 GE Aerospace GEnx engines for Boeing 787s. Discover what this means for widebody economics and investor sentiment. Read more.
Will Smithfield Foods, Inc.’s $1.3bn South Dakota investment reset efficiency standards in U.S. meat processing? (Nasdaq: SFD)
Smithfield Foods, Inc. plans a $1.3B Sioux Falls facility. Discover how automation and strategy could reshape U.S. pork margins and supply chains.
Can AlloyX Limited’s Bahrain FinTech Bay alliance fast-track compliant stablecoin adoption across the Gulf Cooperation Council?
AlloyX Limited partners with Bahrain FinTech Bay to advance regulated stablecoin launch in the GCC. Find out what this means for digital finance.
Why Kyndryl’s AI skilling push in India could reshape its government revenue mix
Kyndryl (NYSE: KD) expands AI skilling in India. Discover how this could reshape public sector contracts and long-term growth strategy.
Hapag-Lloyd AG expands global scale with $4.2bn acquisition of ZIM Integrated Shipping Services Ltd. (NYSE: ZIM)
Hapag-Lloyd AG to acquire ZIM Integrated Shipping Services Ltd. for $4.2B in cash. Discover what this means for global shipping and investors.
From pilots to production: why Cognizant Corporation is betting big on agentic AI at scale (NASDAQ: CTSH)
Cognizant Corporation deepens its Google Cloud partnership to scale agentic AI. Discover what this means for enterprise execution and AI services growth.
Can AMD and Tata Consultancy Services turn Helios into India’s sovereign AI backbone?
AMD and Tata Consultancy Services unveil Helios AI infrastructure blueprint for India. Discover what it means for sovereign AI and hyperscalers.
FDA clearance of Stealth AXiS highlights growing demand for unified spine surgery platforms
Medtronic plc wins FDA clearance for Stealth AXiS. Discover how unified spine robotics could reshape hospital strategy and investor expectations.
Is biomarker-enriched trial design the key to solving schizophrenia cognition failures?
Can biomarker-enriched trials solve schizophrenia cognition failures? Explore Alto Neuroscience’s strategy and what Phase 2 data could mean next.